Clinical Trials Directory

Trials / Unknown

UnknownNCT04512222

EARLY-MYO-AF Registry

EARLY-MYO-AF (EARLY Integrated Therapies on MYOcardial Function Improvements in Patients With Atrial Fibrillation) Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this registry is to depict the myocardial function improvement in AF patients by integrated therapy and to assess the prognostic discrepancies of various intervention modalities. Information will be collected prospectively in about 5000 AF patients. Subjects will be followed for up to 3 years.

Detailed description

This is a prospective, single-centered, non-randomized, observational registry study of AF patients that undergo radio-frequency catheter ablation, left atrial appendage occlusion or surgical ablation. Information of other medication intervention and clinical outcomes are also prospectively collected in the database. This project will establish a prospective registry of 5000 AF patients with follow-ups of up to 3 years. The aim of the project will be as following: 1. To investigate pathophysiological changes of both atrial and ventricular myocardial function in AF patients. 2. To identify clinical indices (including baseline, comorbidities, medication or operational interventions) that are associated with adverse clinical outcomes. 3. To spot potential therapeutical targets in the continuum of AF: from risk-factors elimination to mortality and disability prevalence reduciton.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2022-12-31
Completion
2025-12-31
First posted
2020-08-13
Last updated
2020-08-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04512222. Inclusion in this directory is not an endorsement.